Impact of Vitamin D Level and Supplement on SLE Patients During COVID-19 Pandemic
Impact of Vitamin D Level and Supplement on SLE Patients During COVID-19 Pandemic
Aim of the work Impact of serum vit D level in SLE patients with COVID-19 disease on severity
 of infection, duration of COVID-19 disease course, fatigue development as a complication for
 both SLE and COVID-19 and assess impact of prior chloroquine on COVID-19 disease outcomes
 Patients and methods 38 SLE patients previously diagnosed and on different lines of lupus
 management. Participants were presented to chest outpatient clinic and emergency hospital,
 Mansoura University with manifestation suggesting COVID-19 infection. Serum vit D was
 measured in serum by ELISA.
Primary objective: assess the impact of serum vit D level in SLE patients with COVID-19
 disease on severity of infection and pandemic treatment outcome.

 Secondary objectives:

 -  Effect of serum vit D level in SLE patients on duration of COVID-19 disease course and
 fatigue development as a complication for both SLE and COVID-19

 -  Impact of prior chloroquine on COVID-19 disease outcomes

 -  Correlation of serum vit D level with different laboratory investigations at time of
 COVID-19 outbreak
Inclusion Criteria:

 -  - SLE patients previously diagnosed

 -  Patients are not suffering from malignancies.

 -  Patients have no organ failure nor uncontrolled medical illness.

 -  Recent COVID-19 infection

 Exclusion Criteria:

 -  - Pregnant, lactating females

 -  Concurrent malignancies

 -  Patients with other autoimmune disease